Actualités dans la gestion des syndromes coronariens aigus

More documents

Recommendations

Info

AHA Guidelines Circu<strong>la</strong>tion nov 2009
Clopidogrel response variability for loading doses (300 vs 600 mg) Patients (%) 33 30 27 24 21 18 15 12 9 6 3 0 Resistance = 28% (300 mg) Resistance = 8% (600 mg) 300 mg clopidogrel 600 mg clopidogrel ≤−30 (−20,−10] (0,10] (20,30] (40,50] (60,70] (−30,−20] (−10,0] (10,20] (30,40] (50,60] > 70 Δ A (5 μM ADP-induced Aggregation) at 24 h Gurbel PA J Am Coll Cardiol. 2005;45:1392
Page 1 and 2: Actualités s 2010 pour la prise en
Page 3 and 4: douleur thoracique douleur persista
Page 5 and 6: Recommandations Européennes (ESC 2
Page 7 and 8: Le seul objectif du traitement de l
Page 9 and 10: Reperfusion Therapy: Important Time
Page 11 and 12: Stratégie de reperfusion d’un SC
Page 13 and 14: Angiography after Fibrinolytic Ther
Page 15 and 16: Fibrinolytic Therapy: Antithromboti
Page 17 and 18: Thrombolysis vs primary PCI : 1 Yr
Page 19 and 20: Peut on améliorer les délais % d
Page 21: Décès, FV, choc cardiogénique à
Page 25 and 26: 15 TRITON study : Primary Endpoint
Page 27 and 28: * Range ±7 7 days 3602 pts with ST
Page 29: 1-Year Death or Reinfarction Death
Page 32 and 33: CK release during reperfusion CK re
Page 34 and 35: Recommandations Européennes (ESC 2
Page 36 and 37: Critères pour le bilan coronarogra
Page 38 and 39: ACUITY - Primary Results UFH/Enoxap
Page 40 and 41: 96-Hour Primary Efficacy Results Ro
Page 42 and 43: ABOARD : Individual Ischemic Endpoi

Actualités dans la gestion des syndromes coronariens aigus

Create successful ePaper yourself

Delete template?

Save as template?